Inhibrx Biosciences Inc.
(INBX)
undefined
undefined%
At close: undefined
14.62
0.07%
After-hours Dec 13, 2024, 04:00 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -1.86 | -1.70 | -5.08 | -2.75 | -3.67 | -4.48 | -7.64 | -22.80 |
| PS Ratio | 248.74 | 113.44 | 58.24 | 16.26 | 20.73 | 18.62 | 18.68 | 28.28 |
| PB Ratio | 10.29 | 4.26 | 7.92 | 2.76 | -2.01 | -2.42 | -5.16 | -20.39 |
| P/FCF Ratio | -2.26 | -2.13 | -5.11 | -4.22 | -5.56 | -5.70 | -7.39 | -10.29 |
| P/OCF Ratio | -2.32 | -2.14 | -5.17 | -4.34 | -5.88 | -6.05 | -7.92 | -10.41 |
| OCF/S Ratio | -26.85 | -13.23 | -2.82 | -0.94 | -0.88 | -0.77 | -0.59 | -0.68 |
| Debt / Equity Ratio | 1.20 | 0.88 | 0.34 | 0.12 | -0.11 | -0.04 | -0.13 | -0.51 |
| Quick Ratio | 1.36 | 2.55 | 1.56 | 2.08 | 0.15 | 0.05 | 0.40 | 0.97 |
| Current Ratio | 1.31 | 2.54 | 1.55 | 1.05 | 0.19 | 0.09 | 0.43 | 0.97 |
| Asset Turnover | 0.01 | 0.01 | 0.05 | 0.09 | 0.34 | 0.75 | 0.46 | 0.31 |
| Interest Coverage | -1.72 | -2.00 | -3.67 | -1.56 | -1.91 | -4.99 | -2.32 | 0.00 |
| Return on Equity (ROE) | -554.81% | -250.14% | -156.10% | -100.22% | 54.93% | 54.06% | 67.57% | 89.42% |
| Return on Assets (ROA) | -78.39% | -49.93% | -54.35% | -52.62% | -194.04% | -312.13% | -112.73% | -38.87% |
| Return on Capital (ROIC) | -87.14% | -49.04% | -59.82% | -60.03% | -738.54% | 476.17% | -236.94% | -75.95% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.15% | 0.23% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.66% | -1.77% | 0.00% |
| Gross Profit Margin | 8.46% | -7.67% | 15.57% | -118.46% | -106.71% | -86.51% | -55.22% | -38.72% |
| Net Profit Margin | -3352.24% | -1666.97% | -286.91% | -147.64% | -141.32% | -103.88% | -61.14% | -31.01% |